Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 5/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4018867 | 1.00 | DNM1 (0.48) | DNM1OPRM1FAAHEPHX2CNR1 | |
| SCHEMBL9136425 | 1.00 | DNM1 (0.48) | DNM1OPRM1FAAHEPHX2CNR1 | |
| SCHEMBL10350856 | 1.00 | DNM1 (0.48) | DNM1OPRM1FAAHEPHX2CNR1 | |
| SCHEMBL17253503 | 1.00 | DNM1 (0.48) | DNM1OPRM1FAAHEPHX2CNR1 | |
| SCHEMBL4022359 | 1.00 | DNM1 (0.48) | DNM1OPRM1FAAHEPHX2CNR1 | |
| SCHEMBL19219115 | 1.00 | DNM1 (0.48) | DNM1OPRM1FAAHEPHX2CNR1 | |
| SCHEMBL3039218 | 1.00 | DNM1 (0.48) | DNM1OPRM1FAAHEPHX2CNR1 | |
| SCHEMBL7082641 | 1.00 | DNM1 (0.48) | DNM1OPRM1FAAHEPHX2CNR1 | |
| SCHEMBL11673316 | 1.00 | DNM1 (0.48) | DNM1OPRM1FAAHEPHX2CNR1 | |
| SCHEMBL11631045 | 1.00 | DNM1 (0.48) | DNM1OPRM1FAAHEPHX2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110079378-A | A kind of environment-friendly type fin punching oil and preparation method thereof | 上海中孚特种油品有限公司 | 2019-08-02 | — | — | CN | claimed |
| EP-4736836-A1 | TWO-LAYER SEPARATION TYPE COMPOSITION | Kao Corporation (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260098007-A1 | Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light | SOLIOME INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-12558379-B2 | Compositions and methods relating to pooled fetal support tissue | BIOTISSUE HOLDINGS INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-12496341-B2 | Methods for reducing anergy in lymphocytes using modulators of MYC | HTYR ACQUISITION LLC (US) | 2025-12-16 | — | — | US | disclosed |
| EP-3986430-B1 | METHODS OF PROMOTING VASCULOGENESIS | BIOTISSUE HOLDINGS INC (US) | 2025-08-06 | — | — | EP | disclosed |
| EP-4587635-A2 | FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS | Evolved by Nature, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| EP-4587007-A2 | COMPOUNDS AND THEIR USE IN FILTERING ULTRAVIOLET AND/OR HIGH-ENERGY VISIBLE LIGHT | Soliome, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20250230203-A1 | FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS | EVOLVED BY NATURE, INC. | 2025-07-17 | — | — | US | disclosed |
| US-12318467-B2 | Cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2025-06-03 | — | — | US | disclosed |
| EP-0570230-A1 | External preparation for skin | SHISEIDO COMPANY LIMITED (JP) | 1993-11-18 | — | — | EP | disclosed |
| US-5176843-A | O-hydroxyaryloximes, alcohol or ester, o-hydroxyarylketoximes; extracting copper | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-01-05 | — | — | US | disclosed |
| US-5153340-A | Moisture permeability, emulsification and hydration; skin lotion, shampoo, hair conditioner and lipstick | AJINOMOTO CO., INC. (JP) | 1992-10-06 | — | — | US | disclosed |
| EP-0443592-A2 | Oil-soluble N-long chained acyl acidic amino acid ester, mixture thereof and perfuming cosmetics containing the same | Ajinomoto Co., Inc. (JP) | 1991-08-28 | — | — | EP | disclosed |
| US-4978788-A | COPPER AS PERCHLORATE USING O-HYDROXYARYLOXIMES AND BRANCHED ALIPHATIC OR AROMATIC ALCOHOLS OR ESTERS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-12-18 | — | — | US | disclosed |
| US-4636525-A | NONIONIC SURFACTANT | POLA CHEMICAL INDUSTRIES, INC. (JP) | 1987-01-13 | — | — | US | disclosed |
| EP-0202833-A2 | Composition and use of the composition for the extraction of metals from aqueous solutions | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-11-26 | — | — | EP | disclosed |
| US-4595537-A | Containing aliphatic alcohol or fatty acid residue | POLA CHEMICAL INDUSTRIES, INC. (JP) | 1986-06-17 | — | — | US | disclosed |
| US-4383001-A | Magnetic recording medium | VICTOR COMPANY OF JAPAN, LIMITED (JP) | 1983-05-10 | — | — | US | disclosed |
| US-4224311-A | Disubstituted derivatives of glycerol and cosmetic compositions containing the same as an oily excipient therefor | L'OREAL (FR) | 1980-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098007-A1 | Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light | UGT8, UGT1A3, FUT5 | DNM1 4729/4885OPRM1 644/4885FAAH 2934/4885 |
| US-12558379-B2 | Compositions and methods relating to pooled fetal support tissue | PGF, MATR3, LGALS3 | DNM1 4831/4885OPRM1 3139/4885FAAH 966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.